Key facts
- This page summarizes Christopher J. Scoggins's Form 4 filing for ABBOTT LABORATORIES (ABT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2026, 20:15.
Christopher J. Scoggins - 27 Feb 2026 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)
- Reporting relationship
- EXECUTIVE VICE PRESIDENT
- Issuer ticker
- ABT
- Reported as of
- 27 Feb 2026
- Net transaction value
- -$580,951
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2026, 20:15:27 UTC
- Prior SEC filing
- 26 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher J. Scoggins by Jessica H. Paik, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Christopher J. Scoggins filed Form 4 for ABBOTT LABORATORIES (ABT) on 03 Mar 2026.
Change
- Previous filing in this sequence was filed on 26 Feb 2026.
- Current net transaction value: -$580,951.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001772286
Primary reporting owner
Scoggins Christopher J
- Relationship
- EXECUTIVE VICE PRESIDENT
- Address
- 100 ABBOTT PARK ROAD, ABBOTT PARK
- Signature
- /s/ Christopher J. Scoggins by Jessica H. Paik, Attorney-in-Fact
- Signature date
- 03 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ABT
transaction
Common shares without par value
Tax liability
- Transaction value
- $580,951
- Shares
- -4,997
- Change %
- -6.1%
- Price
- $116.26
- Shares after
- 77,126
- Date
- 27 Feb 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.